Amylyx “Bulletproof Vest for Neurons” Tested as Potential Alzheimer’s Therapy
In 2013, Amylyx Pharmaceuticals co-founders Justin Klee and Josh Cohen, undergraduate students at Brown University at the time, hypothesized that targeting two dysfunctional pathways…